HONG KONG, Nov. 13, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) (the "Company"), a leading integrated healthcare enterprise in China, is pleased to announce today that it has paid a sum of approximately US$25,230,000 to redeem the 5% redeemable convertible notes due November 2017 in an aggregate principal amount of US$20 million (the "Convertible Notes") from Gem Power International Limited (an indirectly wholly-owned subsidiary of CCB International (Holdings) Limited ).
Following the redemption, the Convertible Notes will be cancelled and the Company will be discharged from all of its obligations under the Convertible Notes.
Details of the redemption of Convertible Notes have been published by the Company in accordance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and posted on the Company's website as follows: http://www.goldenmeditech.com/eng/ir/announcements.php?year=2017
About Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801)
Golden Meditech (www.goldenmeditech.com) is a leading integrated-healthcare enterprise in China. It is a first-mover in China, having established its dominant positions in several markets including the medical devices market, the cord blood storage market and the hospital management market in the healthcare industry, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, Golden Meditech will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.
